CSP EXAM TEST SPECIALTY

• | Page

CSP EXAM TEST (SPECIALTY

PHARMACY)WITH CORRECT

ANSWERS!!

Question : PDC calculation

CORRECT ANSWER : PDC = (# of unique days with

supply / number of days in a period) x 100

Question : Which medication is a Jak inhibitor?

• Humira (adalimumab)
• Orencia (abatacept)
• Actemra (toclizumab)
• Xeljanz (tofacitinib)

CORRECT ANSWER : d. Xeljanz (tofacitinib)

Question : Which medication can elevate cholesterol?

• Actemra (toclizumab)
• Enbrel (etanercept)
• Simponi (golimumab)
• Kineret (anakinra)

• | Page

CORRECT ANSWER : a. Actemra (toclizumab)

Question : Which shingles vaccine is safe to administer

with TNF inhibitors?

• Adacel
• Zostavax
• Shingrix
• Varivax

CORRECT ANSWER : c. Shingrix

Question : Most biologics increase the risk of infections,

which of the following also increases the risk of neutropenia?

• Rituxin (rituximab)
• Taltz (ixekizumab)
• Remicade (infliximab)
• Cimzia (certolizumab pegol)

CORRECT ANSWER : b. Taltz (ixekizumab)

• | Page

Question : Which psoriasis medication does not require

screening for tuberculosis?

• Stelara (ustekinumab)
• Otezla (apremilast)
• Cocentyx (seculinumab)
• Humira (adalimumab)

CORRECT ANSWER : b. Otezla (apremilast)

Question : What is the standard starting dose for Taltz

(ixekizumab) when used to treat psoriatic arthritis?

• 160mg subcutaneously once, followed by 80mg

subcutaneously at weeks 2, 4, 6, 8, 10 and 12; then 80mg subcutaneously every 4 weeks

• 160mg subcutaneously once, followed by 80mg

subcutaneously every 4 weeks

• 160mg subcutaneously once, followed by 80mg

subcutaneously every week for 4 weeks, then 80mg every 4 weeks

• 160mg subcutaneously once, followed by 80mg

subcutaneously every other week

• | Page

CORRECT ANSWER : b. 160mg subcutaneously once,

followed by 80mg subcutaneously every 4 weeks

Question : A 45 y/o, 200lb patient is struggling with

severe dermatitis and the provider wants to potentially start a biologic. Which medication would you recommend?

• Protopic (tacrolimus)
• Humira (adalimumab)
• Stelara (ustekinumab)
• Dupixent (dupilumab)

CORRECT ANSWER : d. Dupixent (dupilumab)

Question : A 56 y/o, 140lb patient with psoriasis will be

starting Stelara (ustekinumab), but the provider wants to verify the dosing of the medication. What starting dose would you recommend?

• Inject 45 mg subcutaneously at weeks 0 and 4,

followed by 45 mg every 12 weeks